27 分钟on MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based ...
The workplace landscape is shifting beneath our feet. Evolving employee expectations, the rise of remote and hybrid work, and widening skills gaps have exposed the limits of credential-centric hiring.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果